Pleiotropic effects of statins: A focus on cancer
- PMID: 32927022
- DOI: 10.1016/j.bbadis.2020.165968
Pleiotropic effects of statins: A focus on cancer
Abstract
The statin drugs ('statins') potently inhibit hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase by competitively blocking the active site of the enzyme. Statins decrease de novo cholesterol biosynthesis and thereby reduce plasma cholesterol levels. Statins exhibit "pleiotropic" properties that are independent of their lipid-lowering effects. For example, preclinical evidence suggests that statins inhibit tumor growth and induce apoptosis in specific cancer cell types. Furthermore, statins show chemo-sensitizing effects by impairing Ras family GTPase signaling. However, whether statins have clinically meaningful anti-cancer effects remains an area of active investigation. Both preclinical and clinical studies on the potential mechanisms of action of statins in several cancers have been reviewed in the literature. Considering the contradictory data on their efficacy, we present an up-to-date summary of the pleiotropic effects of statins in cancer therapy and review their impact on different malignancies. We also discuss the synergistic anti-cancer effects of statins when combined with other more conventional anti-cancer drugs to highlight areas of potential therapeutic development.
Keywords: Apoptosis; Autophagy; Cancer therapy; Chemotherapy; Mevalonate cascade; Prenylation.
Copyright © 2020 Elsevier B.V. All rights reserved.
Similar articles
-
Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.Pharmacol Ther. 2014 Jul;143(1):87-110. doi: 10.1016/j.pharmthera.2014.02.007. Epub 2014 Feb 26. Pharmacol Ther. 2014. PMID: 24582968 Free PMC article. Review.
-
Pleiotropic effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: candidate mechanisms for anti-lipid deposition in blood vessels.Curr Med Chem Cardiovasc Hematol Agents. 2005 Jul;3(3):195-201. doi: 10.2174/1568016054368223. Curr Med Chem Cardiovasc Hematol Agents. 2005. PMID: 15974884 Review.
-
Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins.Int J Mol Med. 2009 Nov;24(5):633-43. doi: 10.3892/ijmm_00000274. Int J Mol Med. 2009. PMID: 19787197 Free PMC article.
-
Could drugs inhibiting the mevalonate pathway also target cancer stem cells?Drug Resist Updat. 2016 Mar;25:13-25. doi: 10.1016/j.drup.2016.02.001. Epub 2016 Feb 20. Drug Resist Updat. 2016. PMID: 27155373 Review.
-
Statins and cancer.Anticancer Agents Med Chem. 2014 Jun;14(5):706-12. doi: 10.2174/1871520613666131129105035. Anticancer Agents Med Chem. 2014. PMID: 24295174 Review.
Cited by
-
Lovastatin-Induced Mitochondrial Oxidative Stress Leads to the Release of mtDNA to Promote Apoptosis by Activating cGAS-STING Pathway in Human Colorectal Cancer Cells.Antioxidants (Basel). 2024 May 31;13(6):679. doi: 10.3390/antiox13060679. Antioxidants (Basel). 2024. PMID: 38929118 Free PMC article.
-
Upregulation of the Mevalonate Pathway through EWSR1-FLI1/EGR2 Regulatory Axis Confers Ewing Cells Exquisite Sensitivity to Statins.Cancers (Basel). 2022 May 8;14(9):2327. doi: 10.3390/cancers14092327. Cancers (Basel). 2022. PMID: 35565457 Free PMC article.
-
Casein Kinase-1-Alpha Inhibitor (D4476) Sensitizes Microsatellite Instable Colorectal Cancer Cells to 5-Fluorouracil via Authophagy Flux Inhibition.Arch Immunol Ther Exp (Warsz). 2021 Sep 18;69(1):26. doi: 10.1007/s00005-021-00629-2. Arch Immunol Ther Exp (Warsz). 2021. PMID: 34536148 Free PMC article.
-
SIAH1 ubiquitination-modified HMGCR inhibits lung cancer progression and promotes drug sensitivity through cholesterol synthesis.Cancer Cell Int. 2023 Apr 16;23(1):71. doi: 10.1186/s12935-023-02914-w. Cancer Cell Int. 2023. PMID: 37062828 Free PMC article.
-
The utility of 3D models to study cholesterol in cancer: Insights and future perspectives.Front Oncol. 2023 Apr 3;13:1156246. doi: 10.3389/fonc.2023.1156246. eCollection 2023. Front Oncol. 2023. PMID: 37077827 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical